CONTINUATION OF TYROSINE KINASE INHIBITORS AFTER CHEMOTHERAPY IN PH plus ACUTE LYMPHOBLASTIC LEUKEMIA

被引：0
|
作者：
Smith, Stephanie [1 ]
Aftandilian, Catherine [1 ]
机构：
[1] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA
来源：
PEDIATRIC BLOOD & CANCER | 2019年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
010
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Assessment of Molecular Response to Tyrosine Kinase Inhibitors in Tunisian Patients With Ph plus Acute Lymphoblastic Leukemia
    Frikha, Rim
    El Aoud, Amina
    Kamoun, Hassen
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S237 - S237
  • [2] Tyrosine kinase inhibitors in Ph plus acute lymphoblastic leukaemia: facts and perspectives
    Malagola, Michele
    Papayannidis, Cristina
    Baccarani, Michele
    ANNALS OF HEMATOLOGY, 2016, 95 (05) : 681 - 693
  • [3] The Efficacy of Tyrosine Kinase Inhibitors with Steroid As First Line Induction Therapy in Ph plus Acute Lymphoblastic Leukemia
    Gurman, Gunhan
    Merter, Mustafa
    Ataca, Pinar
    Ozen, Mehmet
    Atesagaoglu, Berna
    Gunduz, Mehmet
    Pekcan, Gultekin
    Sahin, Ugur
    Toprak, Selami Kocak
    Topcuoglu, Pervin
    Ozcan, Muhit
    Ilhan, Osman
    Atilla, Erden
    BLOOD, 2014, 124 (21)
  • [4] Venetoclax in Combination with Tyrosine Kinase Inhibitors Demonstrates Efficacy in Preclinical Models of Ph plus Acute Lymphoblastic Leukemia
    Minhajuddin, Mohd
    Winters, Amanda C.
    Schwartz, Marc
    Pollyea, Daniel A.
    Jordan, Craig T.
    BLOOD, 2022, 140 : 5986 - 5987
  • [5] MODELING RESISTANCE TO TYROSINE KINASE INHIBITORS IN TEL/ABL plus ACUTE LYMPHOBLASTIC LEUKEMIA
    Zimmermannova, O.
    Zuna, J.
    Machova, K.
    Lizcova, L.
    Zemanova, Z.
    Falkenburg, J.
    Harvey, R.
    Chen, I. M.
    Willman, C. L.
    Trka, J.
    Zaliova, M.
    HAEMATOLOGICA, 2014, 99 : 271 - 272
  • [6] Intensive chemotherapy with tyrosine kinase inhibitors in philadelphia-positive acute lymphoblastic leukemia
    Benavente, Rafael
    Cid, Fernando
    Puga, Barbara
    Molina, Javiera
    Bass, Francisca
    Andrade, Alejandro
    Monardes, Virginia
    Encina, Andrea
    Elena Cabrera, Maria
    REVISTA MEDICA DE CHILE, 2021, 149 (09) : 1249 - 1257
  • [7] Discontinuation of Tyrosine Kinase Inhibitors (TKIs) in Philadelphia Chromosome-Positive (Ph plus ) Acute Lymphoblastic Leukemia (ALL)
    Samra, Bachar
    Kantarjian, Hagop M.
    Sasaki, Koji
    Konopleva, Marina Y.
    Khouri, Rita
    O'Brien, Susan M.
    Ferrajoli, Alessandra
    Nunez, Cesar
    Kadia, Tapan M.
    Jabbour, Elias
    BLOOD, 2019, 134
  • [8] Results of Treatment with Tyrosine Kinase Inhibitors(TKIs) in Combination with Intensive Chemotherapy in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia(Ph plus ALL)
    Kyo, Taiichi
    Okatani, Takeshi
    Kyo, Kouhei
    Imanaka, Ryouta
    Itagaki, Mitsuhiro
    Katayama, Yuuta
    Iwato, Koji
    Asaoku, Hideki
    BLOOD, 2011, 118 (21) : 652 - 652
  • [9] Clinical implications of cytogenetic heterogeneity in Philadelphia chromosome positive (Ph plus ) adult B cell acute lymphoblastic leukemia following tyrosine kinase inhibitors and chemotherapy regimens
    Jain, Poonam
    Gu, Jun
    Kanagal-Shamanna, Rashmi
    Tang, Zhenya
    Patel, Keyur P.
    Yao, Hui
    Fang, Lianghua
    Bao, Hai-Yan
    Liu, Ching-Hua
    Lin, Pei
    Medeiros, L. Jeffrey
    Lu, Xinyan
    LEUKEMIA RESEARCH, 2019, 84
  • [10] Emerging tyrosine kinase inhibitors for the treatment of adult acute lymphoblastic leukemia
    Ansuinelli, Michela
    Cesini, Laura
    Chiaretti, Sabina
    Foa, Robin
    EXPERT OPINION ON EMERGING DRUGS, 2021, 26 (03) : 281 - 294
12345